FDA OKs updated label for ViroPharma's antibiotic Vancocin

12/14/2011 | Wall Street Journal, The

The FDA approved ViroPharma's supplemental new-drug application to include clinical efficacy and safety data on the label of Vancocin, which treats Clostridium difficile infection. ViroPharma says the approval makes the drug eligible for three years of market protection.

View Full Article in:

Wall Street Journal, The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Accreditation
Meridian Health Plan
Detroit, MI
Stop Loss Sales Executive, (Southern Region)
Indigo Insurance Services
Multiple Locations, SL_Multiple Locations
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC